{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:47:17Z","timestamp":1794894437140,"version":"4.9.1"},"reference-count":137,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UEFISCDI-Romania","award":["N-III-P1-1.1-TE-2019-2044"],"award-info":[{"award-number":["N-III-P1-1.1-TE-2019-2044"]}]},{"name":"Romanian Academy","award":["N-III-P1-1.1-TE-2019-2044"],"award-info":[{"award-number":["N-III-P1-1.1-TE-2019-2044"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Apolipoprotein A-II (apoA-II) is the second most abundant apolipoprotein in high-density lipoprotein (HDL) particles, playing an important role in lipid metabolism. Human and murine apoA-II proteins have dissimilar properties, partially because human apoA-II is dimeric whereas the murine homolog is a monomer, suggesting that the role of apoA-II may be quite different in humans and mice. As a component of HDL, apoA-II influences lipid metabolism, being directly or indirectly involved in vascular diseases. Clinical and epidemiological studies resulted in conflicting findings regarding the proatherogenic or atheroprotective role of apoA-II. Human apoA-II deficiency has little influence on lipoprotein levels with no obvious clinical consequences, while murine apoA-II deficiency causes HDL deficit in mice. In humans, an increased plasma apoA-II concentration causes hypertriglyceridemia and lowers HDL levels. This dyslipidemia leads to glucose intolerance, and the ensuing high blood glucose enhances apoA-II transcription, generating a vicious circle that may cause type 2 diabetes (T2D). ApoA-II is also used as a biomarker in various diseases, such as pancreatic cancer. Herein, we provide a review of the most recent findings regarding the roles of apoA-II and its functions in various physiological processes and disease states, such as cardiovascular disease, cancer, amyloidosis, hepatitis, insulin resistance, obesity, and T2D.<\/jats:p>","DOI":"10.3390\/biomedicines10071578","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T11:12:35Z","timestamp":1656760355000},"page":"1578","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Apolipoprotein A-II, a Player in Multiple Processes and Diseases"],"prefix":"10.3390","volume":"10","author":[{"given":"Gabriela","family":"Florea","sequence":"first","affiliation":[{"name":"Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina Florina","family":"Tudorache","sequence":"additional","affiliation":[{"name":"Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9166-8417","authenticated-orcid":false,"given":"Elena Valeria","family":"Fuior","sequence":"additional","affiliation":[{"name":"Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Ionita","sequence":"additional","affiliation":[{"name":"Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina","family":"Dumitrescu","sequence":"additional","affiliation":[{"name":"Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Madalina","family":"Fenyo","sequence":"additional","affiliation":[{"name":"Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2980-3811","authenticated-orcid":false,"given":"Violeta Georgeta","family":"Bivol","sequence":"additional","affiliation":[{"name":"Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-1346","authenticated-orcid":false,"given":"Anca Violeta","family":"Gafencu","sequence":"additional","affiliation":[{"name":"Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d of the Romanian Academy, 050568 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-319-09665-0_2","article-title":"HDL biogenesis, remodeling, and catabolism","volume":"224","author":"Zannis","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1021\/bi300555d","article-title":"Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): Protein conformational ensemble on HDL","volume":"51","author":"Gao","year":"2012","journal-title":"Biochemistry"},{"key":"ref_3","first-page":"822","article-title":"A splice-junction mutation responsible for familial apolipoprotein A-II deficiency","volume":"46","author":"Deeb","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1073\/pnas.93.25.14788","article-title":"Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility","volume":"93","author":"Weng","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0021-9150(98)00096-3","article-title":"Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation","volume":"139","author":"Labeur","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1432-1327.1998.2530328.x","article-title":"The C-terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high-density lipoproteins","volume":"253","author":"Lambert","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/ATVBAHA.109.198226","article-title":"Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome","volume":"30","author":"Julve","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0022-2275(20)30115-2","article-title":"Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II","volume":"43","author":"Boisfer","year":"2002","journal-title":"J. Lipid Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.RES.0000146031.94850.5f","article-title":"Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: A new mechanism linking HDL protein composition and antiatherogenic potential","volume":"95","author":"Ribas","year":"2004","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00366253","article-title":"Regional chromosomal localisation of APOA2 to 1q21\u20131q23","volume":"79","author":"Scott","year":"1988","journal-title":"Hum. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.13.1.1","article-title":"Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice","volume":"13","author":"Mehrabian","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01717324","article-title":"The apolipoprotein multigene family: Structure, expression, evolution, and molecular genetics","volume":"67","author":"Chan","year":"1989","journal-title":"Klin. Wochenschr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/01.ATV.15.3.306","article-title":"Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans","volume":"15","author":"Ikewaki","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"24460","DOI":"10.1016\/S0021-9258(18)54251-4","article-title":"Regulation of the human ApoA-II gene by the synergistic action of factors binding to the proximal and distal regulatory elements","volume":"266","author":"Cardot","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/nar\/17.6.2283","article-title":"Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein-AII enhancer","volume":"17","author":"Lucero","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.ATV.19.6.1456","article-title":"SREBP-1 binds to multiple sites and transactivates the human ApoA-II promoter in vitro: SREBP-1 mutants defective in DNA binding or transcriptional activation repress ApoA-II promoter activity","volume":"19","author":"Pissios","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/nar\/27.4.1104","article-title":"DNA binding specificity and transactivation properties of SREBP-2 bound to multiple sites on the human apoA-II promoter","volume":"27","author":"Kan","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/bj20030549","article-title":"Functional specificity of two hormone response elements present on the human apoA-II promoter that bind retinoid X receptor alpha\/thyroid receptor beta heterodimers for retinoids and thyroids: Synergistic interactions between thyroid receptor beta and upstream stimulatory factor 2a","volume":"376","author":"Hatzivassiliou","year":"2003","journal-title":"Biochem. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9080","DOI":"10.1021\/bi00086a013","article-title":"Factors participating in the liver-specific expression of the human apolipoprotein A-II gene and their significance for transcription","volume":"32","author":"Cardot","year":"1993","journal-title":"Biochemistry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15849","DOI":"10.1016\/S0021-9258(19)49613-0","article-title":"Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3","volume":"267","author":"Ladias","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/MCB.16.7.3350","article-title":"Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor","volume":"16","author":"Schoonjans","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2337\/diabetes.53.3.672","article-title":"In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose","volume":"53","author":"Sauvaget","year":"2004","journal-title":"Diabetes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-5793(97)01127-7","article-title":"Repression of apoC-III gene expression by TNFalpha involves C\/EBPdelta\/NF-IL6beta via an IL-1 independent pathway","volume":"415","author":"Lacorte","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Trusca, V.G., Dumitrescu, M., Fenyo, I.M., Tudorache, I.F., Simionescu, M., and Gafencu, A.V. (2019). The Mechanism of Bisphenol A Atherogenicity Involves Apolipoprotein A-I Downregulation through NF-kappaB Activation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246281"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21776","DOI":"10.1074\/jbc.M611422200","article-title":"Inflammatory signaling pathways regulating ApoE gene expression in macrophages","volume":"282","author":"Gafencu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Trusca, V.G., Fuior, E.V., Kardassis, D., Simionescu, M., and Gafencu, A.V. (2019). The Opposite Effect of c-Jun Transcription Factor on Apolipoprotein E Gene Regulation in Hepatocytes and Macrophages. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061471"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbrc.2015.04.057","article-title":"Metformin reduces the endotoxin-induced down-regulation of apolipoprotein E gene expression in macrophages","volume":"461","author":"Stavri","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ajcn\/nqy081","article-title":"Epigenomics and metabolomics reveal the mechanism of the APOA2-saturated fat intake interaction affecting obesity","volume":"108","author":"Lai","year":"2018","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s100380200101","article-title":"Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: Molecular study in a 1135-member familial hypercholesterolemia kindred","volume":"47","author":"Takada","year":"2002","journal-title":"J. Hum. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/hc3601.095709","article-title":"Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins","volume":"104","author":"Ruotolo","year":"2001","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/jn\/137.9.2024","article-title":"An apolipoprotein A-II polymorphism (\u2212265T\/C, rs5082) regulates postprandial response to a saturated fat overload in healthy men","volume":"137","author":"Tanaka","year":"2007","journal-title":"J. Nutr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2007.11.017","article-title":"The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population","volume":"199","author":"Xiao","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinternmed.2009.343","article-title":"APOA2, dietary fat, and body mass index: Replication of a gene-diet interaction in 3 independent populations","volume":"169","author":"Corella","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ijo.2010.187","article-title":"Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: Replication of a gene-saturated fat interaction","volume":"35","author":"Corella","year":"2011","journal-title":"Int. J. Obes."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.clnu.2015.06.008","article-title":"APOA II genotypes frequency and their interaction with saturated fatty acids consumption on lipid profile of patients with type 2 diabetes","volume":"35","author":"Noorshahi","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1073\/pnas.69.5.1304","article-title":"Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex","volume":"69","author":"Brewer","year":"1972","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-2275(20)38532-1","article-title":"The apolipoprotein multigene family: Biosynthesis, structure, structure-function relationships, and evolution","volume":"29","author":"Li","year":"1988","journal-title":"J. Lipid Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0022-2275(20)31499-1","article-title":"Role of apoA-II in lipid metabolism and atherosclerosis: Advances in the study of an enigmatic protein","volume":"42","author":"Julve","year":"2001","journal-title":"J. Lipid Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: Apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J. Lipid Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.704031","article-title":"Apolipoprotein A-II is inversely associated with risk of future coronary artery disease","volume":"116","author":"Birjmohun","year":"2007","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/S0021-9258(17)34612-4","article-title":"Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction","volume":"253","author":"Weisgraber","year":"1978","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0022-2275(20)41336-7","article-title":"Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins","volume":"33","author":"Via","year":"1992","journal-title":"J. Lipid Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00751-1","article-title":"Apolipoprotein A-II, HDL metabolism and atherosclerosis","volume":"164","author":"Tailleux","year":"2002","journal-title":"Atherosclerosis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1432-1033.1996.0657r.x","article-title":"Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-II","volume":"242","author":"Benetollo","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1021\/bi00041a009","article-title":"Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants","volume":"34","author":"Holvoet","year":"1995","journal-title":"Biochemistry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.csbj.2017.05.003","article-title":"Apolipoprotein E\u2014A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features","volume":"15","author":"Tudorache","year":"2017","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/BF02524284","article-title":"Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles","volume":"31","author":"Murley","year":"1996","journal-title":"Lipids"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Nedelkov, D. (2017). Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes. Proteomes, 5.","DOI":"10.3390\/proteomes5040027"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/07853890.2011.573498","article-title":"Apolipoprotein A-II: Evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis","volume":"44","author":"Chan","year":"2012","journal-title":"Ann. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/j.febslet.2015.02.028","article-title":"Structural stability and functional remodeling of high-density lipoproteins","volume":"589","author":"Gursky","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1021\/pr300963h","article-title":"LC-MS\/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins","volume":"12","author":"Halim","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cell.2015.05.028","article-title":"A Single Kinase Generates the Majority of the Secreted Phosphoproteome","volume":"161","author":"Tagliabracci","year":"2015","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1194\/jlr.M200256-JLR200","article-title":"Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein","volume":"44","author":"Pankhurst","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1093\/nar\/13.17.6387","article-title":"The human apolipoprotein AII gene: Structural organization and sites of expression","volume":"13","author":"Knott","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1016\/S0021-9258(18)53318-4","article-title":"O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins","volume":"268","author":"Remaley","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Honda, K., Okusaka, T., Felix, K., Nakamori, S., Sata, N., Nagai, H., Ioka, T., Tsuchida, A., Shimahara, T., and Shimahara, M. (2012). Altered plasma apolipoprotein modifications in patients with pancreatic cancer: Protein characterization and multi-institutional validation. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046908"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2217\/bmm-2016-0209","article-title":"Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer","volume":"10","author":"Honda","year":"2016","journal-title":"Biomark. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbrc.2018.02.170","article-title":"Serum apolipoprotein A2 isoforms in autoimmune pancreatitis","volume":"497","author":"Kobayashi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/14737159.2019.1643718","article-title":"Trends in biomarker discoveries for the early detection and risk stratification of pancreatic cancer using omics studies","volume":"19","author":"Kobayashi","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/CBM-210198","article-title":"Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms","volume":"33","author":"Honda","year":"2022","journal-title":"Cancer Biomark."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacl.2016.03.001","article-title":"Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes","volume":"10","author":"Azizkhanian","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e019890","DOI":"10.1161\/JAHA.120.019890","article-title":"Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study","volume":"10","author":"Wilkins","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5551\/jat.56218","article-title":"Apolipoprotein A2 Isoforms in Relation to the Risk of Myocardial Infarction: A Nested Case-Control Analysis in the JPHC Study","volume":"28","author":"Kihara","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"20676","DOI":"10.1016\/S0021-9258(20)80777-7","article-title":"Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice","volume":"268","author":"Hedrick","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"21630","DOI":"10.1016\/S0021-9258(19)36658-X","article-title":"Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice","volume":"267","author":"Schultz","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI119554","article-title":"Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles","volume":"100","author":"Castellani","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"31532","DOI":"10.1038\/srep31532","article-title":"Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I\/A-II HDL Particles in Human Plasma","volume":"6","author":"Kido","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1194\/jlr.M075382","article-title":"Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1","volume":"58","author":"Melchior","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1016\/S0021-9258(19)85761-7","article-title":"In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II","volume":"255","author":"Lagocki","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7555\/JBR.33.20190048","article-title":"Pleiotropic effects of apolipoprotein A- on high-density lipoprotein functionality, adipose tissue metabolic activity and plasma glucose homeostasis","volume":"34","author":"Zvintzou","year":"2019","journal-title":"J. Biomed. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2337\/diabetes.50.3.643","article-title":"Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance","volume":"50","author":"Castellani","year":"2001","journal-title":"Diabetes"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Kluth, O., Matzke, D., Kamitz, A., Jahnert, M., Vogel, H., Scherneck, S., Schulze, M., Staiger, H., Machicao, F., and Haring, H.U. (2015). Identification of Four Mouse Diabetes Candidate Genes Altering beta-Cell Proliferation. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1005506"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1582-4934.2012.01552.x","article-title":"Inflammation in atherosclerosis: A cause or a result of vascular disorders?","volume":"16","author":"Manduteanu","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/365762a0","article-title":"Protein composition determines the anti-atherogenic properties of HDL in transgenic mice","volume":"365","author":"Schultz","year":"1993","journal-title":"Nature"},{"key":"ref_75","first-page":"128","article-title":"High density lipoprotein: The role of apolipoprotein A2","volume":"9","author":"Xepapadaki","year":"2019","journal-title":"Hell. J. Atheroscler."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI117726","article-title":"Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein","volume":"95","author":"Watson","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/ATVBAHA.109.190264","article-title":"Expression of human apoAII in transgenic rabbits leads to dyslipidemia: A new model for combined hyperlipidemia","volume":"29","author":"Koike","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/ATVBAHA.109.196683","article-title":"ApoAII controversy still in rabbit?","volume":"29","author":"Shimano","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/ATVBAHA.112.300445","article-title":"Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits","volume":"33","author":"Wang","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2020.11.028","article-title":"Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits","volume":"316","author":"Koike","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1194\/jlr.M400345-JLR200","article-title":"Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II","volume":"45","author":"Castellani","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.8332912","article-title":"Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II","volume":"261","author":"Warden","year":"1993","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-2275(20)42832-9","article-title":"Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I","volume":"31","author":"Khoo","year":"1990","journal-title":"J. Lipid Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1074\/jbc.274.17.11564","article-title":"Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis","volume":"274","author":"Boisfer","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.RES.0000075600.87675.16","article-title":"Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia","volume":"92","author":"Allayee","year":"2003","journal-title":"Circ. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biochi.2013.08.027","article-title":"Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes","volume":"96","author":"Maiga","year":"2014","journal-title":"Biochimie"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9149(01)02148-8","article-title":"Targeting low high-density lipoprotein cholesterol for therapy: Lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial","volume":"88","author":"Robins","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"Rubins","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/STROKEAHA.115.009663","article-title":"Ratio of Apolipoprotein A-II\/B Improves Risk Prediction of Postoperative Survival After Carotid Endarterectomy","volume":"46","author":"Duschek","year":"2015","journal-title":"Stroke"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12944-017-0619-y","article-title":"ApoA-I\/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator","volume":"16","author":"Kido","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e02033","DOI":"10.1016\/j.heliyon.2019.e02033","article-title":"Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia","volume":"5","author":"Boiko","year":"2019","journal-title":"Heliyon"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0022-2275(20)33441-6","article-title":"Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia","volume":"41","author":"Julve","year":"2000","journal-title":"J. Lipid Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/physrev.00024.2006","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kheniser, K.G., Osme, A., Kim, C., Ilchenko, S., Kasumov, T., and Kashyap, S.R. (2020). Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes. Biomolecules, 10.","DOI":"10.3390\/biom10040520"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"289481","DOI":"10.1155\/2013\/289481","article-title":"APOA2 Polymorphism in Relation to Obesity and Lipid Metabolism","volume":"2013","author":"Zaki","year":"2013","journal-title":"Cholesterol"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/oby.2005.53","article-title":"Apolipoprotein A-II polymorphism and visceral adiposity in African-American and white women","volume":"13","author":"Hunter","year":"2005","journal-title":"Obes. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.mgene.2014.04.007","article-title":"Evaluating the association of APOA2 polymorphism with insulin resistance in adolescents","volume":"2","author":"Zaki","year":"2014","journal-title":"Meta Gene"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11745-002-0981-4","article-title":"Apolipoproteins A-I and A-II downregulate neutrophil functions","volume":"37","author":"Furlaneto","year":"2002","journal-title":"Lipids"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1753425908099171","article-title":"Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein","volume":"14","author":"Thompson","year":"2008","journal-title":"Innate Immun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/09680519050110020501","article-title":"Apolipoproteins modulate the inflammatory response to lipopolysaccharide","volume":"11","author":"Berbee","year":"2005","journal-title":"J. Endotoxin Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1002\/pmic.200401292","article-title":"Reference maps of mouse serum acute-phase proteins: Changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes","volume":"5","author":"Wait","year":"2005","journal-title":"Proteomics"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12944-018-0769-6","article-title":"LpA-II:B:C:D:E: A new immunochemically-defined acute phase lipoprotein in humans","volume":"17","author":"Bagdade","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.4049\/jimmunol.1002924","article-title":"Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function","volume":"186","author":"Yamashita","year":"2011","journal-title":"J. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","article-title":"Hypolipidemia is associated with the severity of COVID-19","volume":"14","author":"Wei","year":"2020","journal-title":"J. Clin. Lipidol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12944-020-01382-9","article-title":"Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: An observational study","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Lassale, C., Hamer, M., Hernaez, A., Gale, C.R., and Batty, G.D. (2021). Association of pre-pandemic high-density lipoprotein cholesterol with risk of COVID-19 hospitalisation and death: The UK Biobank cohort study. medRxiv.","DOI":"10.1101\/2021.01.20.21250152"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/s41598-021-81638-1","article-title":"Altered high-density lipoprotein composition and functions during severe COVID-19","volume":"11","author":"Begue","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Cho, K.H., Kim, J.R., Lee, I.C., and Kwon, H.J. (2021). Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity. Antioxidants, 10.","DOI":"10.3390\/antiox10020209"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Cho, K.H. (2021). Importance of Apolipoprotein A-I and A-II Composition in HDL and Its Potential for Studying COVID-19 and SARS-CoV-2. Medicines, 8.","DOI":"10.3390\/medicines8070038"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"15921","DOI":"10.1038\/srep15921","article-title":"Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms","volume":"5","author":"Honda","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mpa.0000250128.57026.b2","article-title":"Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling","volume":"34","author":"Ehmann","year":"2007","journal-title":"Pancreas"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjc.6605764","article-title":"Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis","volume":"103","author":"Xue","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1002\/cam4.2587","article-title":"Apolipoproteins and cancer","volume":"8","author":"Ren","year":"2019","journal-title":"Cancer Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1158\/1078-0432.1073.11.3","article-title":"Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer","volume":"11","author":"Malik","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Julovi, S.M., Xue, A., Thanh, L.T., Gill, A.J., Bulanadi, J.C., Patel, M., Waddington, L.J., Rye, K.A., Moghaddam, M.J., and Smith, R.C. (2016). Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151475"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): A review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/geno.2000.6499","article-title":"A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein AII gene","volume":"72","author":"Benson","year":"2001","journal-title":"Genomics"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1046\/j.1523-1755.2001.00024.x","article-title":"Renal amyloidosis caused by a novel stop-codon mutation in the apolipoprotein A-II gene","volume":"60","author":"Yazaki","year":"2001","journal-title":"Kidney Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1523-1755.2003.00047.x","article-title":"Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg","volume":"64","author":"Yazaki","year":"2003","journal-title":"Kidney Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.febslet.2014.01.066","article-title":"Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men","volume":"588","author":"Gursky","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ekir.2017.07.009","article-title":"Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant","volume":"2","author":"Prokaeva","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.kint.2019.03.013","article-title":"A transgenic mouse model reproduces human hereditary systemic amyloidosis","volume":"96","author":"Chabert","year":"2019","journal-title":"Kidney Int."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/13506129.2011.574354011","article-title":"A transgenic mouse model of human systemic ApoA2 amyloidosis","volume":"18","author":"Benson","year":"2011","journal-title":"Amyloid"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/labinvest.2014.158","article-title":"Extracellular deposition of mouse senile AApoAII amyloid fibrils induced different unfolded protein responses in the liver, kidney, and heart","volume":"95","author":"Luo","year":"2015","journal-title":"Lab. Investig."},{"key":"ref_128","first-page":"1535","article-title":"Fibrilization in mouse senile amyloidosis is fibril conformation-dependent","volume":"78","author":"Higuchi","year":"1998","journal-title":"Lab. Investig."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0002-9440(10)63718-2","article-title":"Tissue distribution, biochemical properties, and transmission of mouse type A AApoAII amyloid fibrils","volume":"164","author":"Korenaga","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1194\/jlr.M013235","article-title":"ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis","volume":"52","author":"Wang","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1038\/s41598-018-23755-y","article-title":"Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure","volume":"8","author":"Yang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bbapap.2009.06.028","article-title":"Amyloid fibrils formed by selective N-, C-terminal sequences of mouse apolipoprotein A-II","volume":"1794","author":"Sawashita","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"E836","DOI":"10.1073\/pnas.1416363112","article-title":"C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice","volume":"112","author":"Sawashita","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/13506120309041737","article-title":"Polymorphisms of mouse apolipoprotein A-II: Seven alleles found among 41 inbred strains of mice","volume":"10","author":"Kitagawa","year":"2003","journal-title":"Amyloid"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e63538","DOI":"10.7554\/eLife.63538","article-title":"Curcumin promotes AApoAII amyloidosis and peroxisome proliferation in mice by activating the PPARalpha signaling pathway","volume":"10","author":"Dai","year":"2021","journal-title":"Elife"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Xu, C., Garcia, D., Lu, Y., Ozuna, K., Adjeroh, D.A., Wang, K., and on Behalf of the Alzheimer\u2019s Disease Neuroimaging Initiative (2021). Levels of Angiotensin-Converting Enzyme and Apolipoproteins Are Associated with Alzheimer\u2019s Disease and Cardiovascular Diseases. Cells, 11.","DOI":"10.3390\/cells11010029"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.md.0000200467.51816.6d","article-title":"Lysozyme amyloidosis: Report of 4 cases and a review of the literature","volume":"85","author":"Granel","year":"2006","journal-title":"Medicine"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1578\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:42:01Z","timestamp":1760139721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":137,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["biomedicines10071578"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10071578","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]}}}